Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73M Buy
12,020
+1,428
+13% +$302K 0.05% 310
2026
Q1
$2.01M Buy
10,592
+324
+3% +$64K 0.05% 353
2025
Q4
$1.83M Buy
10,268
+2,519
+33% +$430K 0.04% 374
2025
Q3
$1.26M Sell
7,749
-161
-2% -$27.2K 0.04% 339
2025
Q2
$1.39M Buy
7,910
+5,265
+199% +$933K 0.04% 337
2025
Q1
$479K Sell
2,645
-3,999
-60% -$796K 0.04% 335
2024
Q4
$1.39M Buy
+6,644
New +$1.45M 0.09% 192

Other funds holding IEX

Callan Family Office's IEX Position: Q2 2026 in Review

Callan Family Office increased its IDEX (IEX) stake by 13% in Q2 2026, buying an estimated $302K and bringing the position to 12,020 shares worth $2.73M. The position accounts for 0.05% of the portfolio, ranked #310.

Callan Family Office first reported a position in IEX in Q4 2024 and has held it in 7 quarters since. 691 funds tracked by Wall St. Rank hold IEX as of Q2 2026.

  • Callan Family Office held 12,020 shares of IDEX worth $2.73M as of Q2 2026.
  • Callan Family Office bought 1,428 IDEX shares in Q2 2026, an estimated $302K.
  • IDEX made up 0.05% of Callan Family Office's portfolio in Q2 2026, its #310 holding.
  • Callan Family Office first reported a position in IDEX in Q4 2024 and has held it in 7 quarters since.
  • 691 funds tracked by Wall St. Rank held IDEX as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.